Evidence map›Paper›PMID 34833369›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Shinsuke Suzuki, Satoshi Toyoma, Yohei Kawasaki, Koh Koizumi, Nobuko Iikawa, Kazuhiro Shiina, Tentaro Endo, Tomoe Abe, Teppei Kouga, Takechiyo Yamada

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shinsuke SuzukiDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.ORCID 0000-0001-8555-1722
Satoshi ToyomaDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Yohei KawasakiDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Koh KoizumiDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Nobuko IikawaDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Kazuhiro ShiinaDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Tentaro EndoDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Tomoe AbeDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Teppei KougaDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Takechiyo YamadaDepartment of Otorhinolaryngology & Head and Neck Surgery, Graduate School of Medicine, Akita University, Akita 010-8543, Japan.
Akita University · JP

Funding

Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. grant no. 21K09648
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Head and Neck NeoplasmsImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsCetuximabHumansNeoplasm Recurrence, LocalPaclitaxelRetrospective StudiesSquamous Cell Carcinoma of Head and NeckCetuximabImmune Checkpoint InhibitorsPaclitaxelcetuximabchemotherapyhead and neck squamous cell carcinomaimmune checkpoint inhibitorpaclitaxel

Identifiers

PMID34833369
PMCPMC8621992
OpenAlexW3208709932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.